The Scientist

» patent, ecology and cell & molecular biology

Most Recent

image: Mysterious Mechanisms of Cardiac Cell Therapy

Mysterious Mechanisms of Cardiac Cell Therapy

By | February 4, 2016

Injections of progenitor cells into damaged rat hearts may improve function, but not because the implants themselves are creating new muscle.

1 Comment

image: Capsule Reviews

Capsule Reviews

By | February 1, 2016

What Should a Clever Moose Eat?, The Illusion of God's Presence, GMO Sapiens, and Why We Snap

1 Comment

image: Keep Off the Grass

Keep Off the Grass

By | February 1, 2016

Ecologists focused on grasslands urge policymakers to keep forestation efforts in check.

0 Comments

image: Holding Their Ground

Holding Their Ground

By | February 1, 2016

To protect the global food supply, scientists want to understand—and enhance—plants’ natural resistance to pathogens.

1 Comment

image: Plant Immunity

Plant Immunity

By | February 1, 2016

How plants fight off pathogens

0 Comments

image: Jason Holliday: Tree Tracker

Jason Holliday: Tree Tracker

By | February 1, 2016

Associate Professor, Virginia Tech, Department of Forest Resources and Environmental Conservation. Age: 37

0 Comments

image: Schizophrenia and the Synapse

Schizophrenia and the Synapse

By | January 27, 2016

Genetic evidence suggests that overactive synaptic pruning drives development of schizophrenia.

5 Comments

image: Another Role for ApoE?

Another Role for ApoE?

By | January 20, 2016

Key Alzheimer’s disease–related protein may be a transcriptional regulator.

3 Comments

image: “Heroes of CRISPR” Disputed

“Heroes of CRISPR” Disputed

By | January 19, 2016

Critics have harsh words for the Broad Institute’s Eric Lander and Cell over a recent perspective piece describing the history of CRISPR.

10 Comments

image: Who Owns CRISPR, Cont’d

Who Owns CRISPR, Cont’d

By | January 14, 2016

The US Patent and Trademark Office declares a patent “interference” and will seek to determine who has rights to the gene-editing technology.

1 Comment

Popular Now

  1. How Plants Evolved Different Ways to Make Caffeine
  2. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  3. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  4. Reviewing Results-Free Manuscripts
    The Nutshell Reviewing Results-Free Manuscripts

    An open-access journal is trialing a peer-review process in which reviewers do not have access to the results or discussion sections of submitted papers.

RayBiotech